Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
Rankning i aktier #41014
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
Aktiekurs
$0.00185055
Marknadsvärde
$48.29K
Förändring (1 dag)
-3.55%
Förändring (1 år)
30.31%
Land
GB
Handel Nuformix plc (NFX)

Kategori

P/S-tal för Nuformix plc (NFX)
P/S-tal per September 2026 TTM: 0.00
Enligt Nuformix plc senaste finansiella rapporter och aktiekurs är det aktuella P/S-talet (TTM) 0.00. I slutet av 2024 hade företaget ett P/S-tal på 0.00.
Historik för P/S-tal för Nuformix plc från 2014 till 2026
P/S-tal vid årets slut
År P/S-tal Ändra
2026 (TTM) 0.00 0.00%
2025 0.00 0.00%
2024 0.00 0.00%
2023 0.00 -100.00%
2022 116.70 74.68%
2021 66.81 87.30%
2020 35.67 81.62%
2019 19.64 -95.96%
2018 485.61 0.00%
2017 0.00 -100.00%
2016 2.23 0.00%
2014 0.00 0.00%
P/S-tal för liknande företag eller konkurrenter
Företag P/S-tal Skillnad i P/S-tal Land
10.44 -
US
26.12 -
US
3.76 -
AU
12.01 -
NL
- -
CH